$0.852000
-0.0070-0.81%
At Close: -
$0.880000
0.033.29%
After Hours: 5:44 PM EDT
15 minutes delayed
Comments
Loading...
Sonnet BioTherapeutics
SONNNASDAQ
Sonnet BioTherapeutics (SONN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sonnet BioTherapeutics (NASDAQ:SONN) Stock Quotes, Forecast and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open | $0.88 |
| Close | $0.85 |
| Volume / Avg. | 29.95K / 42.59K |
| Day Range | 0.83 - 0.88 |
| 52 Wk Range | 0.83 - 10.09 |
| Market Cap | $4.59M |
| P/E Ratio | 0.31 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 0.62% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Sonnet BioTherapeutics Holdings Inc
Sector
Health Care
Industry
Biotechnology
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has devel...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.
Who are Sonnet BioTherapeutics (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Genprex (NASDAQ:GNPX) and Portage Biotech (NASDAQ:PRTG).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
There is no analysis for Sonnet BioTherapeutics.
What is the forecast for Sonnet BioTherapeutics (SONN) stock?
Sonnet BioTherapeutics has a consensus price target of $8.53.
Current stock price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $0.88 last updated July 23, 2024 at 5:44 PM EDT.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There are no upcoming dividends for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q3 earnings are confirmed for Monday, August 12, 2024.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.